To include your compound in the COVID-19 Resource Center, submit it here.

Amikacin Fosfomycin Inhalation System: Phase II started

Cardeas began the double-blind, placebo-controlled, international Phase II IASIS trial to evaluate Amikacin Fosfomycin Inhalation System delivered twice daily

Read the full 192 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE